Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Maple MAGA who wrote (1562415)	10/3/2025 10:52:55 AM
From: combjelly	2 Recommendations Recommended By Eric pocotrader Read Replies (2) \| Respond to of 1577019

Sigh. A breakthrough occurred in 1949, when poliovirus was successfully cultivated in human tissue by John Enders, Thomas Weller and Frederick Robbins at Boston Children’s Hospital. Their pioneering work was recognized with the 1954 Nobel Prize. Not long afterwards, in the early 1950s, the first successful vaccine was created by US physician Jonas Salk. Salk tested his experimental killed-virus vaccine on himself and his family in 1953, and a year later on 1.6 million children in Canada, Finland and the USA. The results were announced on 12 April 1955, and Salk’s inactivated polio vaccine (IPV) was licensed on the same day. By 1957, annual cases dropped from 58 000 to 5600, and by 1961, only 161 cases remained. who.int First tested in 1953 on Salk and his family. Clinicals with 1.6 million a year later. Licensed in 1955 is not the long, drawn out process your described which was more like a decade. And then you changed the subject to the platform. Gish galloping along. Please engage in your mental masturbation in private. It is kind of icky.